Rank | Gene Set | Z-score |
---|---|---|
1 | desmosome organization (GO:0002934) | 5.36309666 |
2 | positive regulation of cellular amide metabolic process (GO:0034250) | 5.13927607 |
3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.87384604 |
4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.87384604 |
5 | modulation by symbiont of host immune response (GO:0052553) | 4.87384604 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.87384604 |
7 | modulation by symbiont of host defense response (GO:0052031) | 4.87384604 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.87384604 |
9 | protein localization to endosome (GO:0036010) | 4.20624281 |
10 | microglial cell activation (GO:0001774) | 3.85080702 |
11 | barbed-end actin filament capping (GO:0051016) | 3.78837852 |
12 | macrophage activation involved in immune response (GO:0002281) | 3.78357527 |
13 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.56858482 |
14 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.56164210 |
15 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.43869592 |
16 | response to host immune response (GO:0052572) | 3.43869592 |
17 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.41358142 |
18 | skin morphogenesis (GO:0043589) | 3.37836768 |
19 | epithelial cell-cell adhesion (GO:0090136) | 3.22495140 |
20 | pinocytosis (GO:0006907) | 3.21533267 |
21 | response to host (GO:0075136) | 3.20532219 |
22 | response to host defenses (GO:0052200) | 3.20532219 |
23 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.20532219 |
24 | apoptotic cell clearance (GO:0043277) | 3.19878928 |
25 | endothelial cell chemotaxis (GO:0035767) | 3.19854111 |
26 | mannose metabolic process (GO:0006013) | 3.19671135 |
27 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.18978273 |
28 | positive regulation of heat generation (GO:0031652) | 3.10735433 |
29 | regulation of water loss via skin (GO:0033561) | 3.10710307 |
30 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.07813079 |
31 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.05945600 |
32 | cell-substrate junction assembly (GO:0007044) | 3.04776917 |
33 | adherens junction assembly (GO:0034333) | 3.02874792 |
34 | cell adhesion mediated by integrin (GO:0033627) | 2.92617711 |
35 | regulation of integrin activation (GO:0033623) | 2.91229375 |
36 | response to laminar fluid shear stress (GO:0034616) | 2.88890502 |
37 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.87490179 |
38 | surfactant homeostasis (GO:0043129) | 2.85819945 |
39 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.84614742 |
40 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.84089942 |
41 | detection of molecule of bacterial origin (GO:0032490) | 2.83013549 |
42 | response to muramyl dipeptide (GO:0032495) | 2.83012154 |
43 | basement membrane organization (GO:0071711) | 2.82414799 |
44 | I-kappaB phosphorylation (GO:0007252) | 2.81576515 |
45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.78471710 |
46 | macrophage activation (GO:0042116) | 2.78229363 |
47 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.78226951 |
48 | cell-cell junction maintenance (GO:0045217) | 2.77791737 |
49 | establishment of skin barrier (GO:0061436) | 2.75866936 |
50 | L-amino acid import (GO:0043092) | 2.74266679 |
51 | apoptotic process involved in morphogenesis (GO:0060561) | 2.72778539 |
52 | regulation of early endosome to late endosome transport (GO:2000641) | 2.71775846 |
53 | glycosphingolipid catabolic process (GO:0046479) | 2.70826846 |
54 | cell-substrate adherens junction assembly (GO:0007045) | 2.64209881 |
55 | focal adhesion assembly (GO:0048041) | 2.64209881 |
56 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.62753131 |
57 | detection of other organism (GO:0098543) | 2.60721803 |
58 | keratinization (GO:0031424) | 2.60512422 |
59 | positive regulation of extracellular matrix organization (GO:1903055) | 2.59118275 |
60 | decidualization (GO:0046697) | 2.53168005 |
61 | detection of bacterium (GO:0016045) | 2.52799683 |
62 | atrioventricular valve morphogenesis (GO:0003181) | 2.52376796 |
63 | cell migration involved in heart development (GO:0060973) | 2.51499365 |
64 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.51233301 |
65 | amino acid import (GO:0043090) | 2.50163934 |
66 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.49650981 |
67 | regulation of plasminogen activation (GO:0010755) | 2.49579310 |
68 | wound healing, spreading of epidermal cells (GO:0035313) | 2.49268200 |
69 | regulation of heat generation (GO:0031650) | 2.49161663 |
70 | semaphorin-plexin signaling pathway (GO:0071526) | 2.49158743 |
71 | tooth mineralization (GO:0034505) | 2.48354312 |
72 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.48033925 |
73 | regulation of cholesterol homeostasis (GO:2000188) | 2.47516965 |
74 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.47077690 |
75 | regulation of apoptotic cell clearance (GO:2000425) | 2.44828819 |
76 | positive regulation of receptor recycling (GO:0001921) | 2.43263461 |
77 | regulation of podosome assembly (GO:0071801) | 2.43251647 |
78 | response to peptidoglycan (GO:0032494) | 2.42094511 |
79 | endodermal cell differentiation (GO:0035987) | 2.40887782 |
80 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.40687338 |
81 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.40685815 |
82 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.40507072 |
83 | embryonic process involved in female pregnancy (GO:0060136) | 2.40274089 |
84 | hemidesmosome assembly (GO:0031581) | 2.39022084 |
85 | regulation of extracellular matrix disassembly (GO:0010715) | 2.36450741 |
86 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.36298974 |
87 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.35903443 |
88 | negative regulation of cell size (GO:0045792) | 2.35609663 |
89 | regulation of tight junction assembly (GO:2000810) | 2.35513907 |
90 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.35276389 |
91 | glycolipid catabolic process (GO:0019377) | 2.35129491 |
92 | positive regulation of p38MAPK cascade (GO:1900745) | 2.34523018 |
93 | regulation of mononuclear cell migration (GO:0071675) | 2.34325685 |
94 | regulation of superoxide anion generation (GO:0032928) | 2.33900598 |
95 | substrate-dependent cell migration (GO:0006929) | 2.31837425 |
96 | regulation of macrophage chemotaxis (GO:0010758) | 2.31765970 |
97 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.31486086 |
98 | amino sugar catabolic process (GO:0046348) | 2.31434041 |
99 | Golgi transport vesicle coating (GO:0048200) | 2.31113067 |
100 | COPI coating of Golgi vesicle (GO:0048205) | 2.31113067 |
101 | embryo implantation (GO:0007566) | 2.30955033 |
102 | positive regulation of antigen processing and presentation (GO:0002579) | 2.30166649 |
103 | negative regulation of lipid storage (GO:0010888) | 2.29745377 |
104 | NIK/NF-kappaB signaling (GO:0038061) | 2.29733430 |
105 | superoxide anion generation (GO:0042554) | 2.29370782 |
106 | regulation of extracellular matrix organization (GO:1903053) | 2.29147831 |
107 | positive regulation of interferon-alpha production (GO:0032727) | 2.28954581 |
108 | negative regulation of cartilage development (GO:0061037) | 2.28879934 |
109 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.28855821 |
110 | virion attachment to host cell (GO:0019062) | 2.26993204 |
111 | adhesion of symbiont to host cell (GO:0044650) | 2.26993204 |
112 | protein retention in ER lumen (GO:0006621) | 2.26610916 |
113 | regulation of lipid kinase activity (GO:0043550) | 2.26440591 |
114 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.26057147 |
115 | negative regulation of catenin import into nucleus (GO:0035414) | 2.25894198 |
116 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.25776851 |
117 | positive regulation of fat cell differentiation (GO:0045600) | 2.23949012 |
118 | glial cell proliferation (GO:0014009) | 2.23368569 |
119 | axon extension involved in axon guidance (GO:0048846) | 2.22289810 |
120 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.22289810 |
121 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.20745385 |
122 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.20083515 |
123 | neutrophil activation involved in immune response (GO:0002283) | 2.19161133 |
124 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.19076447 |
125 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.17800721 |
126 | response to lipoprotein particle (GO:0055094) | 2.16868061 |
127 | myeloid cell activation involved in immune response (GO:0002275) | 2.12302120 |
128 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.12231959 |
129 | positive regulation of cholesterol efflux (GO:0010875) | 2.11942117 |
130 | regulation of interferon-alpha production (GO:0032647) | 2.11731138 |
131 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.11625200 |
132 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.11201457 |
133 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.11037656 |
134 | cytokine secretion (GO:0050663) | 2.08979320 |
135 | regulation of cellular amide metabolic process (GO:0034248) | 2.08625340 |
136 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.08033464 |
137 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.07647006 |
138 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.07132318 |
139 | regulation of beta-amyloid formation (GO:1902003) | 2.06282344 |
140 | positive regulation of macrophage cytokine production (GO:0060907) | 2.05586401 |
141 | detection of biotic stimulus (GO:0009595) | 2.05122332 |
142 | regulation of macrophage cytokine production (GO:0010935) | 2.03398808 |
143 | regulation of fever generation (GO:0031620) | 2.03229501 |
144 | response to auditory stimulus (GO:0010996) | 2.01671253 |
145 | regulation of cholesterol storage (GO:0010885) | 1.99258412 |
146 | adhesion of symbiont to host (GO:0044406) | 1.98440425 |
147 | wound healing, spreading of cells (GO:0044319) | 1.98353951 |
148 | germinal center formation (GO:0002467) | 1.97520325 |
149 | positive regulation of interleukin-1 secretion (GO:0050716) | 1.97510432 |
150 | detection of external biotic stimulus (GO:0098581) | 1.96931777 |
151 | regulation of alkaline phosphatase activity (GO:0010692) | 1.94945693 |
152 | positive regulation of chemokine biosynthetic process (GO:0045080) | 1.94241013 |
153 | ganglion development (GO:0061548) | 1.93529556 |
154 | stress fiber assembly (GO:0043149) | 1.93251212 |
155 | regulation of interleukin-1 beta secretion (GO:0050706) | 1.92167203 |
156 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 1.91037046 |
157 | modulation by symbiont of host cellular process (GO:0044068) | 1.87811938 |
158 | granulocyte activation (GO:0036230) | 1.87348897 |
159 | regulation of platelet aggregation (GO:0090330) | 1.86844388 |
160 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 1.86341597 |
161 | ovulation cycle (GO:0042698) | 1.86260628 |
162 | protein kinase C signaling (GO:0070528) | 1.86085084 |
163 | ruffle organization (GO:0031529) | 1.85255330 |
164 | regulation of antigen processing and presentation (GO:0002577) | 1.84982804 |
165 | positive regulation of interleukin-1 beta production (GO:0032731) | 1.84759504 |
166 | negative regulation of granulocyte differentiation (GO:0030853) | 1.84623766 |
167 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 1.84314002 |
168 | chondroitin sulfate catabolic process (GO:0030207) | 1.83699564 |
169 | response to cholesterol (GO:0070723) | 1.83513989 |
170 | regulation of interleukin-1 secretion (GO:0050704) | 1.82790369 |
Rank | Gene Set | Z-score |
---|---|---|
1 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.63891490 |
2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.63559945 |
3 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.60610097 |
4 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.56918601 |
5 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.38270673 |
6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.36260068 |
7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.36095779 |
8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.15913819 |
9 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.14430404 |
10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.08379584 |
11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.97570799 |
12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.97000476 |
13 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.91408104 |
14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.91371907 |
15 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.90899228 |
16 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.87680881 |
17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.85481097 |
18 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.84655318 |
19 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.84326287 |
20 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.80227382 |
21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.77371482 |
22 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.75449052 |
23 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.74795415 |
24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.74689958 |
25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.70907422 |
26 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.66414096 |
27 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.64831392 |
28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.64651788 |
29 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.64454986 |
30 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.64106780 |
31 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.63320695 |
32 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.62137715 |
33 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.62053833 |
34 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.61799034 |
35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.60671160 |
36 | MYC_22102868_ChIP-Seq_BL_Human | 1.60440338 |
37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58746340 |
38 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.56985346 |
39 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.56437818 |
40 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.56247973 |
41 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.55171502 |
42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54927899 |
43 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.54039466 |
44 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.53810647 |
45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.52406124 |
46 | TP53_16413492_ChIP-PET_HCT116_Human | 1.51073476 |
47 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.48767447 |
48 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.48685925 |
49 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.45822669 |
50 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45799818 |
51 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.45333606 |
52 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.43480696 |
53 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.43468449 |
54 | CJUN_26792858_Chip-Seq_BT549_Human | 1.43178152 |
55 | RXR_22108803_ChIP-Seq_LS180_Human | 1.41119437 |
56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.39610037 |
57 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34632848 |
58 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.34432455 |
59 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32944580 |
60 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.31941716 |
61 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.31514282 |
62 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.30969701 |
63 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.30441178 |
64 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.29132200 |
65 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.28813777 |
66 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.28706255 |
67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.28279503 |
68 | ATF3_27146783_Chip-Seq_COLON_Human | 1.27763639 |
69 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26935176 |
70 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.26743407 |
71 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.26380428 |
72 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.25251172 |
73 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24787565 |
74 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.24782582 |
75 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.24120264 |
76 | P68_20966046_ChIP-Seq_HELA_Human | 1.23991693 |
77 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.23082786 |
78 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.22852985 |
79 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.21592334 |
80 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.21592334 |
81 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.21295006 |
82 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.21295006 |
83 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.21295006 |
84 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.21291178 |
85 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.20821576 |
86 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.20821576 |
87 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.20753241 |
88 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.20680636 |
89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20581609 |
90 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.20425792 |
91 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19632269 |
92 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19199889 |
93 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.18297311 |
94 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.18122723 |
95 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.17890408 |
96 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.17486803 |
97 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.17305814 |
98 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16765447 |
99 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.16663381 |
100 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.16296193 |
101 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.16072674 |
102 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15815419 |
103 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.14896511 |
104 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14714373 |
105 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14470550 |
106 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.14063745 |
107 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13915300 |
108 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.13807611 |
109 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.13183108 |
110 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.13022652 |
111 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.12821085 |
112 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.12636468 |
113 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.12026939 |
114 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.11430179 |
115 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11264419 |
116 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10170904 |
117 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09975052 |
118 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09804304 |
119 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.09360457 |
120 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.09346928 |
121 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09079534 |
122 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08788885 |
123 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.08475794 |
124 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.08045523 |
125 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.07952202 |
126 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07170075 |
127 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.06987966 |
128 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06708438 |
129 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06286759 |
130 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.06079313 |
131 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.05400144 |
132 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.04871893 |
133 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.04731686 |
134 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.04613776 |
135 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.04352452 |
136 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04076843 |
137 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.03774769 |
138 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.02839974 |
139 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.02839974 |
140 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02311693 |
141 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02311130 |
142 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.01877629 |
143 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01460333 |
144 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01108362 |
145 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.01027388 |
146 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.00891841 |
147 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99704296 |
148 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.98915252 |
149 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98890970 |
150 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.98480849 |
151 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98315142 |
152 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97969060 |
153 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.97081808 |
154 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.95726530 |
155 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.94768068 |
156 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.94374992 |
157 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.93711573 |
158 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.93256607 |
159 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89682961 |
160 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.88608400 |
161 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.86838257 |
162 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86512731 |
163 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.86328513 |
164 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86207216 |
165 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86103818 |
166 | KDM2B_26808549_Chip-Seq_K562_Human | 0.85441888 |
167 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.84630690 |
168 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.84215406 |
169 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83683013 |
170 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.82685948 |
171 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82169059 |
172 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.81013742 |
173 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.80872295 |
174 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.79945662 |
175 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.79471545 |
176 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.78936057 |
177 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.78665370 |
178 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.78446970 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000569_abnormal_digit_pigmentation | 5.28983608 |
2 | MP0005058_abnormal_lysosome_morphology | 3.55578235 |
3 | MP0002254_reproductive_system_inflammat | 3.20906895 |
4 | MP0004510_myositis | 2.87318266 |
5 | MP0003172_abnormal_lysosome_physiology | 2.86650785 |
6 | MP0008438_abnormal_cutaneous_collagen | 2.79457807 |
7 | MP0001849_ear_inflammation | 2.59561710 |
8 | MP0005257_abnormal_intraocular_pressure | 2.58347582 |
9 | MP0001958_emphysema | 2.39444727 |
10 | MP0010234_abnormal_vibrissa_follicle | 2.34684345 |
11 | MP0003690_abnormal_glial_cell | 2.30244539 |
12 | MP0004858_abnormal_nervous_system | 2.27810787 |
13 | MP0008260_abnormal_autophagy | 2.23719371 |
14 | MP0003705_abnormal_hypodermis_morpholog | 2.15787450 |
15 | MP0003303_peritoneal_inflammation | 2.09495959 |
16 | MP0005076_abnormal_cell_differentiation | 2.04342813 |
17 | MP0003566_abnormal_cell_adhesion | 2.03730693 |
18 | MP0002419_abnormal_innate_immunity | 1.96316442 |
19 | MP0001835_abnormal_antigen_presentation | 1.95159652 |
20 | MP0003075_altered_response_to | 1.90517217 |
21 | MP0005023_abnormal_wound_healing | 1.90226203 |
22 | MP0005275_abnormal_skin_tensile | 1.87387232 |
23 | MP0005167_abnormal_blood-brain_barrier | 1.86846866 |
24 | MP0000604_amyloidosis | 1.84892556 |
25 | MP0004947_skin_inflammation | 1.84205790 |
26 | MP0003091_abnormal_cell_migration | 1.81798801 |
27 | MP0010030_abnormal_orbit_morphology | 1.77187058 |
28 | MP0003300_gastrointestinal_ulcer | 1.76483076 |
29 | MP0002998_abnormal_bone_remodeling | 1.66908869 |
30 | MP0003045_fibrosis | 1.64395764 |
31 | MP0005501_abnormal_skin_physiology | 1.63581473 |
32 | MP0003941_abnormal_skin_development | 1.61660841 |
33 | MP0004264_abnormal_extraembryonic_tissu | 1.59635121 |
34 | MP0009840_abnormal_foam_cell | 1.59573828 |
35 | MP0001216_abnormal_epidermal_layer | 1.54059664 |
36 | MP0003279_aneurysm | 1.51963524 |
37 | MP0005409_darkened_coat_color | 1.50868403 |
38 | MP0000858_altered_metastatic_potential | 1.49424487 |
39 | MP0006082_CNS_inflammation | 1.46871846 |
40 | MP0000566_synostosis | 1.46503404 |
41 | MP0003436_decreased_susceptibility_to | 1.44820506 |
42 | MP0003183_abnormal_peptide_metabolism | 1.41896324 |
43 | MP0004130_abnormal_muscle_cell | 1.39273945 |
44 | MP0003448_altered_tumor_morphology | 1.37222645 |
45 | MP0001533_abnormal_skeleton_physiology | 1.36245368 |
46 | MP0003646_muscle_fatigue | 1.36178455 |
47 | MP0009764_decreased_sensitivity_to | 1.35545711 |
48 | MP0000767_abnormal_smooth_muscle | 1.35137725 |
49 | MP0003724_increased_susceptibility_to | 1.33801346 |
50 | MP0000467_abnormal_esophagus_morphology | 1.32704059 |
51 | MP0003191_abnormal_cellular_cholesterol | 1.32566698 |
52 | MP0001790_abnormal_immune_system | 1.32432414 |
53 | MP0005387_immune_system_phenotype | 1.32432414 |
54 | MP0000343_altered_response_to | 1.31788679 |
55 | MP0009278_abnormal_bone_marrow | 1.30864641 |
56 | MP0002148_abnormal_hypersensitivity_rea | 1.28617678 |
57 | MP0000383_abnormal_hair_follicle | 1.24388155 |
58 | MP0005464_abnormal_platelet_physiology | 1.23518845 |
59 | MP0001851_eye_inflammation | 1.22288453 |
60 | MP0005377_hearing/vestibular/ear_phenot | 1.22003642 |
61 | MP0003878_abnormal_ear_physiology | 1.22003642 |
62 | MP0005310_abnormal_salivary_gland | 1.21832982 |
63 | MP0005025_abnormal_response_to | 1.21110146 |
64 | MP0005166_decreased_susceptibility_to | 1.20766512 |
65 | MP0004859_abnormal_synaptic_plasticity | 1.18666366 |
66 | MP0004185_abnormal_adipocyte_glucose | 1.17774651 |
67 | MP0005000_abnormal_immune_tolerance | 1.17555932 |
68 | MP0002452_abnormal_antigen_presenting | 1.16425598 |
69 | MP0002295_abnormal_pulmonary_circulatio | 1.16007355 |
70 | MP0009785_altered_susceptibility_to | 1.15005973 |
71 | MP0009053_abnormal_anal_canal | 1.14588869 |
72 | MP0000579_abnormal_nail_morphology | 1.13852176 |
73 | MP0002060_abnormal_skin_morphology | 1.13453824 |
74 | MP0002098_abnormal_vibrissa_morphology | 1.10757893 |
75 | MP0003453_abnormal_keratinocyte_physiol | 1.09263566 |
76 | MP0000762_abnormal_tongue_morphology | 1.09059132 |
77 | MP0002090_abnormal_vision | 1.08924601 |
78 | MP0010352_gastrointestinal_tract_polyps | 1.06594158 |
79 | MP0002089_abnormal_postnatal_growth/wei | 1.03940422 |
80 | MP0002896_abnormal_bone_mineralization | 1.03401048 |
81 | MP0009384_cardiac_valve_regurgitation | 1.01530744 |
82 | MP0010678_abnormal_skin_adnexa | 0.99913723 |
83 | MP0008004_abnormal_stomach_pH | 0.99546587 |
84 | MP0005174_abnormal_tail_pigmentation | 0.99439425 |
85 | MP0010368_abnormal_lymphatic_system | 0.98485327 |
86 | MP0004233_abnormal_muscle_weight | 0.95627157 |
87 | MP0001915_intracranial_hemorrhage | 0.94687870 |
88 | MP0002168_other_aberrant_phenotype | 0.94493258 |
89 | MP0001879_abnormal_lymphatic_vessel | 0.94299533 |
90 | MP0000377_abnormal_hair_follicle | 0.93662915 |
91 | MP0001853_heart_inflammation | 0.93263754 |
92 | MP0002877_abnormal_melanocyte_morpholog | 0.92365661 |
93 | MP0005666_abnormal_adipose_tissue | 0.91317152 |
94 | MP0002332_abnormal_exercise_endurance | 0.91029265 |
95 | MP0004272_abnormal_basement_membrane | 0.90794829 |
96 | MP0000733_abnormal_muscle_development | 0.90555814 |
97 | MP0006054_spinal_hemorrhage | 0.90434104 |
98 | MP0000015_abnormal_ear_pigmentation | 0.90096686 |
99 | MP0010771_integument_phenotype | 0.89785469 |
100 | MP0005390_skeleton_phenotype | 0.89722438 |
101 | MP0001501_abnormal_sleep_pattern | 0.89512216 |
102 | MP0009931_abnormal_skin_appearance | 0.88532379 |
103 | MP0002006_tumorigenesis | 0.88511369 |
104 | MP0002723_abnormal_immune_serum | 0.88393146 |
105 | MP0003828_pulmonary_edema | 0.88109465 |
106 | MP0003634_abnormal_glial_cell | 0.85586976 |
107 | MP0000678_abnormal_parathyroid_gland | 0.85474921 |
108 | MP0003329_amyloid_beta_deposits | 0.82619113 |
109 | MP0005375_adipose_tissue_phenotype | 0.82293180 |
110 | MP0005388_respiratory_system_phenotype | 0.81523200 |
111 | MP0002133_abnormal_respiratory_system | 0.81523200 |
112 | MP0001243_abnormal_dermal_layer | 0.81468873 |
113 | MP0000003_abnormal_adipose_tissue | 0.80860328 |
114 | MP0000685_abnormal_immune_system | 0.79480939 |
115 | MP0002138_abnormal_hepatobiliary_system | 0.79168025 |
116 | MP0005595_abnormal_vascular_smooth | 0.78388301 |
117 | MP0001800_abnormal_humoral_immune | 0.77969789 |
118 | MP0005197_abnormal_uvea_morphology | 0.77570546 |
119 | MP0005508_abnormal_skeleton_morphology | 0.76689030 |
120 | MP0005451_abnormal_body_composition | 0.76344204 |
121 | MP0001819_abnormal_immune_cell | 0.73921524 |
122 | MP0001299_abnormal_eye_distance/ | 0.73038946 |
123 | MP0001502_abnormal_circadian_rhythm | 0.71955160 |
124 | MP0009672_abnormal_birth_weight | 0.71188814 |
125 | MP0009780_abnormal_chondrocyte_physiolo | 0.71074500 |
126 | MP0005164_abnormal_response_to | 0.70972988 |
127 | MP0010386_abnormal_urinary_bladder | 0.70912560 |
128 | MP0000249_abnormal_blood_vessel | 0.70461471 |
129 | MP0002420_abnormal_adaptive_immunity | 0.70411708 |
130 | MP0001614_abnormal_blood_vessel | 0.70377699 |
131 | MP0001348_abnormal_lacrimal_gland | 0.69409844 |
132 | MP0004782_abnormal_surfactant_physiolog | 0.69370084 |
133 | MP0000751_myopathy | 0.68698913 |
134 | MP0005670_abnormal_white_adipose | 0.68577615 |
135 | MP0000647_abnormal_sebaceous_gland | 0.68113631 |
136 | MP0000537_abnormal_urethra_morphology | 0.67816755 |
137 | MP0000371_diluted_coat_color | 0.67551744 |
138 | MP0002796_impaired_skin_barrier | 0.67082194 |
139 | MP0009333_abnormal_splenocyte_physiolog | 0.66586728 |
140 | MP0000920_abnormal_myelination | 0.66510396 |
141 | MP0002933_joint_inflammation | 0.65338080 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 3.75355919 |
2 | Thick nail (HP:0001805) | 3.68166315 |
3 | Recurrent bacterial skin infections (HP:0005406) | 3.48863441 |
4 | Increased cerebral lipofuscin (HP:0011813) | 3.23451108 |
5 | Eczematoid dermatitis (HP:0000976) | 3.17761042 |
6 | Cervical subluxation (HP:0003308) | 3.09847027 |
7 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.09019114 |
8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.09019114 |
9 | Abnormality of glycolipid metabolism (HP:0010969) | 3.09019114 |
10 | Abnormality of nail color (HP:0100643) | 3.03792519 |
11 | Cerebral aneurysm (HP:0004944) | 2.99202143 |
12 | Axonal loss (HP:0003447) | 2.98302234 |
13 | Aplasia involving bones of the extremities (HP:0009825) | 2.97265689 |
14 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.97265689 |
15 | Aplasia of the phalanges of the hand (HP:0009802) | 2.97265689 |
16 | Broad metatarsal (HP:0001783) | 2.94706539 |
17 | Pulmonary artery stenosis (HP:0004415) | 2.86286369 |
18 | Shallow orbits (HP:0000586) | 2.80581520 |
19 | Gingivitis (HP:0000230) | 2.66386638 |
20 | Nuclear cataract (HP:0100018) | 2.63712640 |
21 | Systemic lupus erythematosus (HP:0002725) | 2.61351386 |
22 | Broad face (HP:0000283) | 2.60892640 |
23 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.59661102 |
24 | Vacuolated lymphocytes (HP:0001922) | 2.58649720 |
25 | Premature rupture of membranes (HP:0001788) | 2.57329316 |
26 | Atrophic scars (HP:0001075) | 2.57132147 |
27 | Periodontitis (HP:0000704) | 2.56156751 |
28 | Arterial tortuosity (HP:0005116) | 2.53089484 |
29 | Alopecia of scalp (HP:0002293) | 2.51892524 |
30 | Hematochezia (HP:0002573) | 2.51143533 |
31 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.48954775 |
32 | Polygenic inheritance (HP:0010982) | 2.48098077 |
33 | Turricephaly (HP:0000262) | 2.45153418 |
34 | Abnormality of macrophages (HP:0004311) | 2.43106890 |
35 | Increased IgE level (HP:0003212) | 2.42297789 |
36 | Absent frontal sinuses (HP:0002688) | 2.38821086 |
37 | Vascular tortuosity (HP:0004948) | 2.36791890 |
38 | Myocardial infarction (HP:0001658) | 2.35950625 |
39 | Distal lower limb amyotrophy (HP:0008944) | 2.34313887 |
40 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.33076494 |
41 | Osteolytic defects of the hand bones (HP:0009699) | 2.33076494 |
42 | Hyperacusis (HP:0010780) | 2.31550019 |
43 | Flat acetabular roof (HP:0003180) | 2.31482924 |
44 | Aortic dissection (HP:0002647) | 2.31254584 |
45 | Biconcave vertebral bodies (HP:0004586) | 2.30959826 |
46 | Natal tooth (HP:0000695) | 2.30114784 |
47 | Autoimmune thrombocytopenia (HP:0001973) | 2.29205057 |
48 | Tetraparesis (HP:0002273) | 2.28763714 |
49 | Obstructive sleep apnea (HP:0002870) | 2.27599973 |
50 | Spontaneous hematomas (HP:0007420) | 2.27319837 |
51 | Thin bony cortex (HP:0002753) | 2.25957870 |
52 | Increased connective tissue (HP:0009025) | 2.23614768 |
53 | Amyloidosis (HP:0011034) | 2.22442724 |
54 | Disproportionate tall stature (HP:0001519) | 2.18825418 |
55 | Dysostosis multiplex (HP:0000943) | 2.18117065 |
56 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.17725758 |
57 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.17725758 |
58 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.17725758 |
59 | Orchitis (HP:0100796) | 2.15981717 |
60 | Aortic aneurysm (HP:0004942) | 2.14989485 |
61 | Follicular hyperkeratosis (HP:0007502) | 2.13358994 |
62 | Lower limb amyotrophy (HP:0007210) | 2.12151702 |
63 | Spondylolisthesis (HP:0003302) | 2.11774289 |
64 | Selective tooth agenesis (HP:0001592) | 2.10537985 |
65 | Premature loss of primary teeth (HP:0006323) | 2.07494132 |
66 | Advanced eruption of teeth (HP:0006288) | 2.05130631 |
67 | Abnormality of complement system (HP:0005339) | 2.02288738 |
68 | Blue sclerae (HP:0000592) | 2.01772196 |
69 | Recurrent skin infections (HP:0001581) | 2.01030778 |
70 | Neurofibrillary tangles (HP:0002185) | 1.98625283 |
71 | Distal lower limb muscle weakness (HP:0009053) | 1.98420133 |
72 | Abnormality of the salivary glands (HP:0010286) | 1.97896257 |
73 | Short nail (HP:0001799) | 1.97464458 |
74 | Prostate neoplasm (HP:0100787) | 1.96680110 |
75 | Malnutrition (HP:0004395) | 1.96548051 |
76 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.95737056 |
77 | Cerebral inclusion bodies (HP:0100314) | 1.93035051 |
78 | Stomatitis (HP:0010280) | 1.91909165 |
79 | Mediastinal lymphadenopathy (HP:0100721) | 1.91904645 |
80 | Frequent falls (HP:0002359) | 1.91248697 |
81 | Megalencephaly (HP:0001355) | 1.91117600 |
82 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.89858728 |
83 | Fragile nails (HP:0001808) | 1.89704166 |
84 | Milia (HP:0001056) | 1.89245244 |
85 | Optic neuritis (HP:0100653) | 1.88368324 |
86 | Retrobulbar optic neuritis (HP:0100654) | 1.88368324 |
87 | Abnormality of the frontal sinuses (HP:0002687) | 1.88180056 |
88 | Mitral valve prolapse (HP:0001634) | 1.86908625 |
89 | Mitral regurgitation (HP:0001653) | 1.86396134 |
90 | Nail dystrophy (HP:0008404) | 1.85095429 |
91 | Palmar hyperkeratosis (HP:0010765) | 1.82168876 |
92 | Supranuclear gaze palsy (HP:0000605) | 1.80850045 |
93 | Upper motor neuron abnormality (HP:0002127) | 1.80480287 |
94 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.78619282 |
95 | Bell-shaped thorax (HP:0001591) | 1.78489927 |
96 | Mucopolysacchariduria (HP:0008155) | 1.78465795 |
97 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.78465795 |
98 | Complement deficiency (HP:0004431) | 1.78373103 |
99 | Vertebral compression fractures (HP:0002953) | 1.77836099 |
100 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.77214593 |
101 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.76333398 |
102 | Peritonitis (HP:0002586) | 1.75576150 |
103 | Genu recurvatum (HP:0002816) | 1.74904571 |
104 | Spinal rigidity (HP:0003306) | 1.74846223 |
105 | Syringomyelia (HP:0003396) | 1.74341006 |
106 | Spinal cord lesions (HP:0100561) | 1.74341006 |
107 | Achilles tendon contracture (HP:0001771) | 1.73754830 |
108 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.73065223 |
109 | Bone pain (HP:0002653) | 1.71758611 |
110 | Myositis (HP:0100614) | 1.71703356 |
111 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.71609952 |
112 | Type 1 muscle fiber predominance (HP:0003803) | 1.71131945 |
113 | Dilatation of the ascending aorta (HP:0005111) | 1.70358949 |
114 | Nephritis (HP:0000123) | 1.69428377 |
115 | Abnormal ossification of hand bones (HP:0005921) | 1.69139733 |
116 | Peripheral demyelination (HP:0011096) | 1.68528416 |
117 | Aneurysm (HP:0002617) | 1.68495977 |
118 | Glomerulonephritis (HP:0000099) | 1.68359035 |
119 | Neuronal loss in central nervous system (HP:0002529) | 1.68017460 |
120 | Ulnar bowing (HP:0003031) | 1.67674009 |
121 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.67235996 |
122 | Protrusio acetabuli (HP:0003179) | 1.66839961 |
123 | Abnormality of the lumbar spine (HP:0100712) | 1.66826240 |
124 | Esophageal varix (HP:0002040) | 1.66716203 |
125 | Elevated alkaline phosphatase (HP:0003155) | 1.66604686 |
126 | Interstitial pulmonary disease (HP:0006530) | 1.66466424 |
127 | Right ventricular cardiomyopathy (HP:0011663) | 1.66387086 |
128 | Loss of speech (HP:0002371) | 1.66074854 |
129 | Deep venous thrombosis (HP:0002625) | 1.65602608 |
130 | Fragile skin (HP:0001030) | 1.64997914 |
131 | Difficulty climbing stairs (HP:0003551) | 1.64700758 |
132 | Short hallux (HP:0010109) | 1.64414815 |
133 | Conjunctival telangiectasia (HP:0000524) | 1.64223113 |
134 | Joint stiffness (HP:0001387) | 1.64124844 |
135 | Plantar hyperkeratosis (HP:0007556) | 1.63581999 |
136 | Thoracic kyphosis (HP:0002942) | 1.62653322 |
137 | Scapular winging (HP:0003691) | 1.62633645 |
138 | Long palpebral fissure (HP:0000637) | 1.61986231 |
139 | Palmoplantar hyperkeratosis (HP:0000972) | 1.61688904 |
140 | Mixed hearing impairment (HP:0000410) | 1.61421227 |
141 | Craniofacial hyperostosis (HP:0004493) | 1.61020196 |
142 | Hemangiomatosis (HP:0007461) | 1.60966595 |
143 | Abnormality of carpal bone ossification (HP:0006257) | 1.60688692 |
144 | Metaphyseal cupping (HP:0003021) | 1.60600405 |
145 | Abnormality of proline metabolism (HP:0010907) | 1.59286520 |
146 | Hydroxyprolinuria (HP:0003080) | 1.59286520 |
147 | J-shaped sella turcica (HP:0002680) | 1.57712521 |
148 | Adactyly (HP:0009776) | 1.56848504 |
149 | Long toe (HP:0010511) | 1.56708277 |
150 | Bronchomalacia (HP:0002780) | 1.56356704 |
151 | Arterial thrombosis (HP:0004420) | 1.55507427 |
Rank | Gene Set | Z-score |
---|---|---|
1 | SMG1 | 3.14196488 |
2 | MAP3K13 | 2.64526769 |
3 | MAP3K14 | 2.62875494 |
4 | IRAK3 | 2.55685055 |
5 | SIK1 | 2.46207173 |
6 | TTN | 2.45789395 |
7 | LMTK2 | 2.36655196 |
8 | RIPK4 | 2.30119846 |
9 | MAP3K3 | 2.28822801 |
10 | EPHA2 | 2.20388533 |
11 | CAMK1D | 2.20001780 |
12 | NME2 | 2.12830024 |
13 | MAP2K3 | 2.04973343 |
14 | JAK1 | 1.98731307 |
15 | TYK2 | 1.93086029 |
16 | DMPK | 1.88207427 |
17 | TGFBR2 | 1.86015821 |
18 | PAK4 | 1.84257836 |
19 | CAMK1G | 1.80391074 |
20 | LATS1 | 1.75324621 |
21 | EEF2K | 1.74056611 |
22 | RIPK1 | 1.73296776 |
23 | KIT | 1.65820457 |
24 | TBK1 | 1.62587047 |
25 | ICK | 1.61353796 |
26 | TRIB3 | 1.57602508 |
27 | CDC42BPA | 1.57140806 |
28 | MST1R | 1.56915090 |
29 | EPHA4 | 1.45729118 |
30 | SIK2 | 1.44947325 |
31 | IKBKE | 1.43365495 |
32 | CDK12 | 1.42980566 |
33 | TYRO3 | 1.39048073 |
34 | EPHB1 | 1.38346558 |
35 | BMX | 1.37401569 |
36 | MAP3K11 | 1.33489750 |
37 | BLK | 1.31040415 |
38 | PHKG2 | 1.30912278 |
39 | PHKG1 | 1.30912278 |
40 | PRKD2 | 1.26066582 |
41 | KSR2 | 1.23894328 |
42 | NTRK2 | 1.21052562 |
43 | MET | 1.20036624 |
44 | TAOK3 | 1.17882668 |
45 | PAK6 | 1.16701486 |
46 | IKBKB | 1.14675601 |
47 | SGK3 | 1.13140712 |
48 | TRPM7 | 1.10171531 |
49 | TESK1 | 1.09320346 |
50 | DAPK2 | 1.07397847 |
51 | FES | 1.06812374 |
52 | MAP4K1 | 1.05308692 |
53 | DDR2 | 1.05160479 |
54 | NEK9 | 1.04108452 |
55 | MTOR | 1.03825096 |
56 | SGK2 | 1.00555417 |
57 | PTK6 | 1.00063919 |
58 | STK38 | 0.98634272 |
59 | IRAK4 | 0.98238573 |
60 | MATK | 0.97958524 |
61 | MAP3K9 | 0.95944760 |
62 | MAP3K1 | 0.94167030 |
63 | HCK | 0.93685562 |
64 | NTRK1 | 0.92602935 |
65 | PRKAA2 | 0.91662369 |
66 | MAP3K7 | 0.91197205 |
67 | PRKD3 | 0.90606857 |
68 | PDGFRA | 0.90573346 |
69 | PDGFRB | 0.87308424 |
70 | ZAP70 | 0.86782596 |
71 | STK3 | 0.86580302 |
72 | ARAF | 0.85677176 |
73 | CSF1R | 0.83785045 |
74 | MOS | 0.83750801 |
75 | CHUK | 0.83451897 |
76 | JAK2 | 0.80743714 |
77 | PRKCH | 0.78085196 |
78 | MAP3K2 | 0.77907031 |
79 | MUSK | 0.76850683 |
80 | MAPK12 | 0.76742679 |
81 | PTK2 | 0.76632345 |
82 | FGFR3 | 0.75770732 |
83 | TNIK | 0.75743986 |
84 | NUAK1 | 0.75581676 |
85 | PRKG2 | 0.75056791 |
86 | MARK3 | 0.74607596 |
87 | ERN1 | 0.74202275 |
88 | SGK1 | 0.73906523 |
89 | CDK9 | 0.73047539 |
90 | RPS6KL1 | 0.71786070 |
91 | RPS6KC1 | 0.71786070 |
92 | PTK2B | 0.71545851 |
93 | ERBB4 | 0.71025667 |
94 | LRRK2 | 0.68313387 |
95 | CSK | 0.67349219 |
96 | PRKCE | 0.66783881 |
97 | TIE1 | 0.65367537 |
98 | PKN2 | 0.64736859 |
99 | EPHB2 | 0.63234411 |
100 | MAP3K6 | 0.61062345 |
101 | FER | 0.60133792 |
102 | MAP3K8 | 0.59467850 |
103 | ROCK1 | 0.58723688 |
104 | STK10 | 0.58553907 |
105 | MELK | 0.58408582 |
106 | PIK3CA | 0.58266606 |
107 | PKN1 | 0.58035690 |
108 | KDR | 0.57735309 |
109 | CAMKK1 | 0.57398417 |
110 | SGK223 | 0.57311975 |
111 | SGK494 | 0.57311975 |
112 | IRAK2 | 0.56879277 |
113 | PDPK1 | 0.54830864 |
114 | RET | 0.54420628 |
115 | EPHA3 | 0.53939180 |
116 | ABL1 | 0.52547128 |
117 | TAOK1 | 0.51682947 |
118 | * FGR | 0.51306093 |
119 | MAPK15 | 0.51029448 |
120 | PRPF4B | 0.50462092 |
121 | RPS6KA4 | 0.49477357 |
122 | DYRK1B | 0.48809641 |
123 | CDK4 | 0.47647033 |
124 | RPS6KA6 | 0.46945231 |
125 | MARK2 | 0.46689542 |
126 | RPS6KA1 | 0.44658697 |
127 | TAOK2 | 0.43974223 |
128 | MAPKAPK3 | 0.43359783 |
129 | FGFR4 | 0.42832221 |
130 | * JAK3 | 0.42678932 |
131 | CDK6 | 0.42058820 |
132 | RPS6KB2 | 0.41004352 |
133 | LATS2 | 0.40983284 |
134 | MAP3K10 | 0.40653627 |
135 | MAPKAPK2 | 0.40603290 |
136 | IGF1R | 0.40357207 |
137 | MAP2K2 | 0.40220745 |
138 | RPS6KA2 | 0.40172556 |
139 | * SRC | 0.39616703 |
140 | SIK3 | 0.38576039 |
141 | TGFBR1 | 0.38063231 |
142 | PIM2 | 0.37805990 |
143 | CAMK4 | 0.37665328 |
144 | PRKD1 | 0.37619063 |
145 | NEK6 | 0.36859758 |
146 | INSR | 0.36454128 |
147 | ABL2 | 0.36393391 |
148 | MAPK7 | 0.36365308 |
149 | MAP2K1 | 0.35925926 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.06284179 |
2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.91030761 |
3 | Prion diseases_Homo sapiens_hsa05020 | 1.84456237 |
4 | Galactose metabolism_Homo sapiens_hsa00052 | 1.82478463 |
5 | Malaria_Homo sapiens_hsa05144 | 1.77723692 |
6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.70262592 |
7 | Lysosome_Homo sapiens_hsa04142 | 1.64279828 |
8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.63949292 |
9 | Bladder cancer_Homo sapiens_hsa05219 | 1.63929754 |
10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.62608601 |
11 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.47527028 |
12 | Other glycan degradation_Homo sapiens_hsa00511 | 1.42304230 |
13 | Tuberculosis_Homo sapiens_hsa05152 | 1.41107543 |
14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.40284378 |
15 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.34895319 |
16 | Pertussis_Homo sapiens_hsa05133 | 1.33160924 |
17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.29969161 |
18 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.27837694 |
19 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.27625654 |
20 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.22819507 |
21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.22052289 |
22 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.21172604 |
23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.21063463 |
24 | Amoebiasis_Homo sapiens_hsa05146 | 1.19898001 |
25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.18842010 |
26 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.14792248 |
27 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11607264 |
28 | Phagosome_Homo sapiens_hsa04145 | 1.09764729 |
29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.08205713 |
30 | Focal adhesion_Homo sapiens_hsa04510 | 1.06180383 |
31 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.03958136 |
32 | Salmonella infection_Homo sapiens_hsa05132 | 1.03400733 |
33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02473743 |
34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.01743956 |
35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.01459614 |
36 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.99669957 |
37 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.99581580 |
38 | Influenza A_Homo sapiens_hsa05164 | 0.98222697 |
39 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.97784976 |
40 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.97474181 |
41 | Thyroid cancer_Homo sapiens_hsa05216 | 0.96379322 |
42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.96353157 |
43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.96315536 |
44 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.94281603 |
45 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.93329789 |
46 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.93205564 |
47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.92415040 |
48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92357322 |
49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90119860 |
50 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89011376 |
51 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.88585967 |
52 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87238732 |
53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86988729 |
54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86307903 |
55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85915125 |
56 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.82640732 |
57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.82397735 |
58 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81697360 |
59 | Platelet activation_Homo sapiens_hsa04611 | 0.81159928 |
60 | * Endocytosis_Homo sapiens_hsa04144 | 0.81137881 |
61 | Salivary secretion_Homo sapiens_hsa04970 | 0.80439008 |
62 | Apoptosis_Homo sapiens_hsa04210 | 0.80408878 |
63 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.79988488 |
64 | Hepatitis C_Homo sapiens_hsa05160 | 0.78922464 |
65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.78663873 |
66 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.78610623 |
67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78092271 |
68 | Adherens junction_Homo sapiens_hsa04520 | 0.77975898 |
69 | Insulin resistance_Homo sapiens_hsa04931 | 0.77274291 |
70 | Measles_Homo sapiens_hsa05162 | 0.77207093 |
71 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.75887706 |
72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75390045 |
73 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.75316062 |
74 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74836413 |
75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.74782459 |
76 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.74731335 |
77 | Shigellosis_Homo sapiens_hsa05131 | 0.74146749 |
78 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.73421186 |
79 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.73402774 |
80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73045940 |
81 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72467071 |
82 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72383071 |
83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71738274 |
84 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.71091911 |
85 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71061199 |
86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.70615594 |
87 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.70291930 |
88 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.69246022 |
89 | Legionellosis_Homo sapiens_hsa05134 | 0.68846462 |
90 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.68180453 |
91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68154509 |
92 | Pathways in cancer_Homo sapiens_hsa05200 | 0.68031827 |
93 | Prostate cancer_Homo sapiens_hsa05215 | 0.66861246 |
94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66661068 |
95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66631285 |
96 | Glioma_Homo sapiens_hsa05214 | 0.66181238 |
97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65683378 |
98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65678517 |
99 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.65365887 |
100 | Renin secretion_Homo sapiens_hsa04924 | 0.65282715 |
101 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64949217 |
102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63659536 |
103 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.63324744 |
104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63263474 |
105 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.63067532 |
106 | Olfactory transduction_Homo sapiens_hsa04740 | 0.62360633 |
107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61785123 |
108 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.61766902 |
109 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.60958655 |
110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59622392 |
111 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 0.59525744 |
112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59299811 |
113 | Mineral absorption_Homo sapiens_hsa04978 | 0.58770961 |
114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58492429 |
115 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57036296 |
116 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.56778605 |
117 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.56544741 |
118 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.56324764 |
119 | Hepatitis B_Homo sapiens_hsa05161 | 0.56252714 |
120 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55936451 |
121 | Morphine addiction_Homo sapiens_hsa05032 | 0.55151221 |
122 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54856816 |
123 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.54504600 |
124 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.53652338 |
125 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.52919937 |
126 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52817676 |
127 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52789035 |
128 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52609632 |
129 | Tight junction_Homo sapiens_hsa04530 | 0.51945382 |
130 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51734954 |
131 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.49119419 |
132 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.45711543 |
133 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45606336 |
134 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.43775528 |
135 | Axon guidance_Homo sapiens_hsa04360 | 0.40632598 |